中文产业新闻精选评分81Chinese source
再生元Garetosmab获FDA批准用于成人FOP，为全球首款激活素A靶向单抗
再生元 first in class 新药获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
再生元 first in class 新药获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.